rs2298784

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_176787.5(PIGN):​c.1488A>G​(p.Ala496Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0061 in 1,613,146 control chromosomes in the GnomAD database, including 283 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0097 ( 45 hom., cov: 32)
Exomes 𝑓: 0.0057 ( 238 hom. )

Consequence

PIGN
NM_176787.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0200

Publications

4 publications found
Variant links:
Genes affected
PIGN (HGNC:8967): (phosphatidylinositol glycan anchor biosynthesis class N) This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This protein is expressed in the endoplasmic reticulum and transfers phosphoethanolamine (EtNP) to the first mannose of the GPI anchor. Two alternatively spliced variants, which encode an identical isoform, have been reported. [provided by RefSeq, Jul 2008]
PIGN Gene-Disease associations (from GenCC):
  • multiple congenital anomalies-hypotonia-seizures syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, ClinGen, PanelApp Australia
  • Fryns syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 18-62109920-T-C is Benign according to our data. Variant chr18-62109920-T-C is described in ClinVar as Benign. ClinVar VariationId is 472211.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.02 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0629 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGNNM_176787.5 linkc.1488A>G p.Ala496Ala synonymous_variant Exon 17 of 31 ENST00000640252.2 NP_789744.1 O95427A0A024R2C3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGNENST00000640252.2 linkc.1488A>G p.Ala496Ala synonymous_variant Exon 17 of 31 1 NM_176787.5 ENSP00000492233.1 O95427
PIGNENST00000400334.7 linkc.1488A>G p.Ala496Ala synonymous_variant Exon 16 of 30 1 ENSP00000383188.2 O95427
PIGNENST00000638424.1 linkn.1488A>G non_coding_transcript_exon_variant Exon 15 of 29 5 ENSP00000491963.1 A0A1W2PQZ1

Frequencies

GnomAD3 genomes
AF:
0.00967
AC:
1470
AN:
151972
Hom.:
45
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00288
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000787
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.0689
Gnomad SAS
AF:
0.00663
Gnomad FIN
AF:
0.0694
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00281
Gnomad OTH
AF:
0.00766
GnomAD2 exomes
AF:
0.0125
AC:
3110
AN:
248676
AF XY:
0.0124
show subpopulations
Gnomad AFR exome
AF:
0.00252
Gnomad AMR exome
AF:
0.000522
Gnomad ASJ exome
AF:
0.00378
Gnomad EAS exome
AF:
0.0628
Gnomad FIN exome
AF:
0.0654
Gnomad NFE exome
AF:
0.00289
Gnomad OTH exome
AF:
0.0131
GnomAD4 exome
AF:
0.00573
AC:
8369
AN:
1461056
Hom.:
238
Cov.:
30
AF XY:
0.00563
AC XY:
4094
AN XY:
726808
show subpopulations
African (AFR)
AF:
0.00221
AC:
74
AN:
33448
American (AMR)
AF:
0.000627
AC:
28
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.00429
AC:
112
AN:
26122
East Asian (EAS)
AF:
0.0719
AC:
2849
AN:
39606
South Asian (SAS)
AF:
0.00274
AC:
236
AN:
86236
European-Finnish (FIN)
AF:
0.0629
AC:
3357
AN:
53384
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5760
European-Non Finnish (NFE)
AF:
0.00113
AC:
1260
AN:
1111470
Other (OTH)
AF:
0.00738
AC:
445
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
428
856
1284
1712
2140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00966
AC:
1469
AN:
152090
Hom.:
45
Cov.:
32
AF XY:
0.0131
AC XY:
971
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.00287
AC:
119
AN:
41506
American (AMR)
AF:
0.000786
AC:
12
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.0688
AC:
356
AN:
5172
South Asian (SAS)
AF:
0.00684
AC:
33
AN:
4824
European-Finnish (FIN)
AF:
0.0694
AC:
734
AN:
10572
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00281
AC:
191
AN:
67962
Other (OTH)
AF:
0.00711
AC:
15
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
67
134
201
268
335
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00235
Hom.:
5
Bravo
AF:
0.00435
Asia WGS
AF:
0.0330
AC:
114
AN:
3478
EpiCase
AF:
0.000982
EpiControl
AF:
0.000593

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 18, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Aug 19, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Multiple congenital anomalies-hypotonia-seizures syndrome 1 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
8.1
DANN
Benign
0.75
PhyloP100
-0.020
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2298784; hg19: chr18-59777153; COSMIC: COSV62949472; COSMIC: COSV62949472; API